Novavax Ev To Operating Cash Flow from 2010 to 2024
| NVAX Stock | USD 18.17 1.39 7.11% |
EV To Operating Cash Flow | First Reported 2010-12-31 | Previous Quarter (0.26) | Current Value (0.27) | Quarterly Volatility 38.11854717 |
Check Novavax financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novavax's main balance sheet or income statement drivers, such as Depreciation And Amortization of 43.3 M, Interest Expense of 15.1 M or Selling General Administrative of 499.1 M, as well as many indicators such as Price To Sales Ratio of 0.47, Dividend Yield of 0.0066 or Days Sales Outstanding of 97.33. Novavax financial statements analysis is a perfect complement when working with Novavax Valuation or Volatility modules.
Novavax | Ev To Operating Cash Flow |
Latest Novavax's Ev To Operating Cash Flow Growth Pattern
Below is the plot of the Ev To Operating Cash Flow of Novavax over the last few years. It is a valuation metric comparing the company's enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows. Novavax's EV To Operating Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novavax's overall financial position and show how it may be relating to other accounts over time.
| Ev To Operating Cash Flow | 10 Years Trend |
|
Ev To Operating Cash Flow |
| Timeline |
Novavax Ev To Operating Cash Flow Regression Statistics
| Arithmetic Mean | (14.05) | |
| Geometric Mean | 4.41 | |
| Coefficient Of Variation | (271.22) | |
| Mean Deviation | 18.93 | |
| Median | (5.03) | |
| Standard Deviation | 38.12 | |
| Sample Variance | 1,453 | |
| Range | 175 | |
| R-Value | (0) | |
| Mean Square Error | 1,565 | |
| R-Squared | 0.00000566 | |
| Significance | 0.99 | |
| Slope | (0.02) | |
| Total Sum of Squares | 20,342 |
Novavax Ev To Operating Cash Flow History
About Novavax Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Novavax income statement, its balance sheet, and the statement of cash flows. Novavax investors use historical funamental indicators, such as Novavax's Ev To Operating Cash Flow, to determine how well the company is positioned to perform in the future. Although Novavax investors may use each financial statement separately, they are all related. The changes in Novavax's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Novavax's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Novavax Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Novavax. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| EV To Operating Cash Flow | (0.26) | (0.27) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Novavax Stock Analysis
When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.